Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

Who we are

Our Values

We at Tillotts are committed to honest and ethical business conduct in all of our activities, consistent with all applicable laws and the highest professional standards. We treat our employees and business partners with fairness and respect, rewarding loyalty, honesty, entrepreneurship and outstanding performance. We focus on realising the following values

The Tillotts Pharma Code of Business Ethics embodies this commitment and outlines the principles and values applicable to all employees of Tillotts and expected from all our business partners. If you wish to read more, you can find our Code of Business Ethics in its full here.

 

 

Our Vision

Tillotts’ Vision is based on four strategic pillars:

  • Tillotts is a leading international specialty pharmaceutical company with a strong presence in Europe and outstanding partners in the rest of the world. It is part of the Zeria Group.
  • Tillotts offers state-of-the-art services and products for the diagnosis and treatment of patients suffering from diseases and ailments of the digestive (GI) tract.
  • Tillotts has an innovative and well balanced product portfolio from own development as well as through in-licensing and selective acquisitions. It has strong formulation capabilities.
  • Tillotts is a preferred partner for gastroenterologists (GEs) and patients.

Our Mission

Based on our expertise, we strive to offer gastrointestinal (GI) healthcare professionals innovative treatment solutions that can improve patients’ well-being and quality of life. We are engaged in advancing care and are continuing to build a well-balanced portfolio of products for the digestive system through our own development activities, collaborations with third parties and acquisitions.

By combining our energetic and dynamic approach with our in-depth knowledge of the digestive system, we are committed to making a difference for the millions of people worldwide who suffer from GI-diseases. Learn more about inflammatory bowel disease (IBD) and other GI-diseases here

 

Download our Corporate Brochure